Financials
- Market Capitalization 12.56 B
- Employee 9 900
- Founded N/A
- CEO Jeffrey N. Simmons
- Website www.elanco.com
- Headquarter Indiana, United States
- FIGI BBG00LJYS1P8
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-48.15
Relación precio/flujo de caja
2.5
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 613 | VTRS Viatris Inc. - Common Stock | 16.39 USD | +0.74% | -3.36% | -1.27% | +58.36% | 19.09 B USD | ||
| 636 | NBIX Neurocrine Biosciences, Inc. - Common Stock | 174.10 USD | -1.70% | -1.13% | +8.89% | +20.07% | 17.51 B USD | ||
| 876 | RDY Dr. Reddy's Laboratories Ltd | 12.92 USD | -2.12% | -9.84% | -3.51% | -11.93% | 10.78 B USD | ||
| 993 | ALKS Alkermes plc - Ordinary Shares | 51.87 USD | -0.13% | -6.32% | +17.57% | +73.25% | 8.65 B USD |